Richardson Electronics, Ltd. — Form 10-Q Summary
Business context and reporting period. Richardson Electronics designs, manufactures and distributes engineered electronics, power and microwave products, green-energy solutions, customized displays, and healthcare imaging replacement parts and services. This report covers the 13-week second quarter and 26 weeks ended November 26, 2022 (fiscal 2023), compared with the periods ended November 27, 2021. Amounts below are in U.S. dollars; financial statement amounts are in millions unless noted.
Financial results and position
| Metric | Q2 FY2023 | Q2 FY2022 | Six months FY2023 | Six months FY2022 |
|---|---|---|---|---|
| Net sales | $65.9 | $54.0 | $133.5 | $107.7 |
| Gross profit / margin | $21.9 / 33.2% | $17.7 / 32.7% | $44.9 / 33.6% | $34.0 / 31.5% |
| Operating income | $7.2 | $4.5 | $16.0 | $7.3 |
| Net income | $5.5 | $4.1 | $11.9 | $6.8 |
| Diluted EPS, common / Class B | $0.39 / $0.35 | $0.30 / $0.27 | $0.83 / $0.75 | $0.50 / $0.45 |
- Q2 sales increased 22.1%; six-month sales increased 23.9%. SG&A rose in dollars, to $14.7 million for the quarter and $28.9 million for six months, but declined as a share of sales to 22.3% and 21.7%, respectively.
- Six-month operating cash flow was negative $7.2 million, versus negative $0.2 million a year earlier. Working-capital changes used $21.5 million, principally from a $18.1 million inventory increase and $5.5 million increase in receivables. Q2 operating cash flow was negative $3.9 million.
- Six-month capital expenditures were $2.7 million; cash dividends paid were $1.7 million. Cash and cash equivalents were $26.1 million at period-end, down from $35.5 million at May 28, 2022. Including $5.0 million of current investments, cash and investments totaled $31.1 million.
- Current assets were $165.9 million and current liabilities $42.7 million. Total liabilities were $45.0 million; the balance sheet lists $2.5 million of lease liabilities and no separate borrowings. The filing does not provide a clear value for any borrowing facility or available credit.
- Effective tax rate was 21.5% for Q2 and 23.4% for the first half, compared with 11.8% and 9.6%, respectively, in the prior-year periods. Management attributed the higher rates primarily to the absence of NOLs available for use, year-end valuation-allowance changes, geographic income mix and state taxes.
Material changes and segment performance
- Gross margin improved year over year, supported by product mix in PMT, product mix and manufacturing efficiencies in GES, and—in the six-month period—improved manufacturing absorption and lower component scrap in Healthcare. Canvys faced unfavorable mix and foreign-currency effects.
- GES was established as a separate reportable segment in fiscal 2023 by carving it out of PMT; prior-year segment results were recast. Q2 sales were PMT $40.6 million (+10.2%), GES $12.3 million (+150.3%), Canvys $10.1 million (+10.2%) and Healthcare $2.9 million (-4.7%). GES growth reflected wind, synthetic-diamond and electric-vehicle demand. PMT growth included semiconductor wafer-fabrication and RF/microwave products.
- Six-month segment sales were PMT $85.9 million (+11.2%), GES $20.8 million (+177.9%), Canvys $20.5 million (+16.5%) and Healthcare $6.2 million (+16.5%).
- Foreign-exchange losses contributed to other expense: $0.2 million in Q2 and $0.6 million for six months. The company says it does not use derivatives to manage foreign-currency exposure.
Outlook, risks and other notable items
- No numerical earnings or sales guidance is provided. Management believes existing liquidity and expected operating cash flows are sufficient for known capital and working-capital needs over the next 12 months, while noting that results are not necessarily indicative of the full fiscal year.
- Risks include uncertain COVID-19 effects on demand, supply chains, freight and product development; currency fluctuations; macroeconomic and labor conditions; and Russia’s invasion of Ukraine and related sanctions. China-origin products are subject to additional U.S. tariffs; inability to pass costs through could pressure sales and margins.
- Management reported disclosure controls were effective and no material changes in internal control over financial reporting. The filing reports no material changes to previously disclosed risk factors. It does not describe a material legal proceeding in the supplied text.
- The company paid a German tax audit assessment in Q2 relating to fiscal 2015–2018. It reported a $3.4 million valuation allowance, primarily related to foreign tax credits and other deferred tax assets, and $0.1 million of uncertain tax positions excluding interest and penalties.
Important facts for investors to verify
- Whether elevated inventory and receivables convert to cash, given substantial first-half operating cash use and inventory growth.
- Whether GES’s rapid growth is sustained and whether its margins and customer demand remain resilient.
- How supply-chain conditions, tariffs, foreign exchange and Canvys/Healthcare product mix affect gross margins.
- Cash availability by geography: $31.1 million of cash and investments included $13.7 million in North America, $9.1 million in Europe, $1.4 million in Latin America and $6.9 million in Asia/Pacific; no funds were repatriated in the first half.
- Tax-rate and valuation-allowance developments, and the board’s discretion over future dividends.